US 8399493
Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
granted A61PA61P25/00A61P25/04
Quick answer
US patent 8399493 (Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors) held by Addex Pharmaceuticals S.A. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharmaceuticals S.A.
- Grant date
- Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P25/00, A61P25/04, A61P25/06, A61P25/08